- 英文名称
- Sweroside
- 分子式
- C16H22O9
- 分子量
- 358.34
- 中文别名
- (4aS,5R,6S)-6-(((2S,3R,4S,5S,6R)-3,4,5-三羟基-6-(羟甲基)四氢-2H-吡喃-2-基)氧基)-5-乙烯基-4,4a,5,6-四氢-1H,3H-吡喃并[3,4-c]吡喃-1-酮; 当药苷; 獐芽菜苷; 当归甙; (4aS,5R,6S)-6-(((2S,3R,4S,5S,6R)-3,4,5-Trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)-5-vinyl-4,4a,5,6-tetrahydro-1H,3H-pyrano[3,4-c]pyran-1-one; (-)-Sweroside; (4aS,5R,6S)-5-ethenyl-1-oxo-4,4a,5,6-tetrahydro-1H,3H-pyrano[3,4-c]pyran-6-yl β-D-glucopyranoside; (4aS,5R,6S)-1-Oxo-5-vinyl-4,4a,5,6-tetrahydro-1H,3H-pyrano[3,4-c]pyran-6-yl β-D-glucopyranoside; (4aS,5R,6S)-5-Ethenyl-6-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4,4a,5,6-tetrahydro-3H-pyrano[3,4-c]pyran-1-one; 5-ethenyl-6-(β-D-glucopyranosyloxy)-4,4a,5,6-tetrahydro-1H,3H-Pyrano[3,4-c]pyran-1-one, (4aS,5R,6S)-
- 用途
- 作为当药的有效成分，具有保护肝脏的作用，用于当药片和当飞利肝宁胶囊的生产；在生命科学领域用于抗炎、镇痛、抗肿瘤、保肝等药理实验及含量测定/鉴定。
